Jilin Zhongke Bio-Engineering Joint Stock Co., Ltd.

Overview

Jilin Zhongke Bio-Engineering Joint Stock Co., Ltd. is a biopharmaceutical company headquartered in China, specializing in the development, manufacturing, and marketing of biological products. The company focuses on innovative solutions in biotechnology research, particularly in human health applications.

Therapeutic areas

API / Drug Master Files

Jilin Zhongke Bio-Engineering Joint Stock Co., Ltd. holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• EXOSOMEActive2026-03-04

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Jilin Zhongke Bio-Engineering Joint Stock Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.